The effect of anti-tuberculosis drugs therapy on mRNA efflux pump gene expression of Rv1250 in Mycobacterium tuberculosis collected from tuberculosis patients

Efflux pumps are transmembrane proteins that vigorously participate in extruding a wide range of substrates, including drugs, outside the bacterial cell. We aimed to investigate the mRNA expression level of the Rv1250 efflux pump gene in Mycobacterium tuberculosis isolated from individuals with tube...

Full description

Bibliographic Details
Main Authors: F. Umar, M. Hatta, D.R. Husain, R. Natzir, R. Dwiyanti, A.R. Junita, M.R. Primaguna
Format: Article
Language:English
Published: Elsevier 2019-11-01
Series:New Microbes and New Infections
Online Access:http://www.sciencedirect.com/science/article/pii/S2052297519301064
id doaj-f4edd3ede7bb45f3818f246ac133faa9
record_format Article
spelling doaj-f4edd3ede7bb45f3818f246ac133faa92020-11-25T01:32:09ZengElsevierNew Microbes and New Infections2052-29752019-11-0132The effect of anti-tuberculosis drugs therapy on mRNA efflux pump gene expression of Rv1250 in Mycobacterium tuberculosis collected from tuberculosis patientsF. Umar0M. Hatta1D.R. Husain2R. Natzir3R. Dwiyanti4A.R. Junita5M.R. Primaguna6Makassar Medical State Laboratory, Indonesian Ministry of Health, Makassar, Indonesia; Post Graduate Programme of Medical Science, Faculty of Medicine, University of Hasanuddin, Makassar, IndonesiaMolecular Biology and Immunology Laboratory, Faculty of Medicine, University of Hasanuddin, Makassar, Indonesia; Corresponding author: M. Hatta, Molecular Biology and Immunology Laboratory, Faculty of Medicine, Hasanuddin University, Jl. Perintis Kemerdekaan KM.10, Makassar 90245, Indonesia.Department of Biology, Faculty of Science, University of Hasanuddin, Makassar, IndonesiaDepartment of Biochemistry, Faculty of Medicine, University of Hasanuddin, Makassar, IndonesiaDepartment of Microbiology, Faculty of Medicine, Tadulako University, Palu, IndonesiaPost Graduate Programme of Medical Science, Faculty of Medicine, University of Hasanuddin, Makassar, Indonesia; Molecular Biology and Immunology Laboratory, Faculty of Medicine, University of Hasanuddin, Makassar, IndonesiaDepartment of Internal Medicine, Faculty of Medicine, Hasanuddin University, Makassar, IndonesiaEfflux pumps are transmembrane proteins that vigorously participate in extruding a wide range of substrates, including drugs, outside the bacterial cell. We aimed to investigate the mRNA expression level of the Rv1250 efflux pump gene in Mycobacterium tuberculosis isolated from individuals with tuberculosis who received drug therapy, at the 1st, 3rd and 5th months, and newly diagnosed patients with tuberculosis who will receive drug therapy (0 month). The study was a multiple cross-sectional longitudinal design—50 different M. tuberculosis isolates and a reference strain H37Rv were subcultured in LJ medium and confirmed by multiplex PCR for identification of M. tuberculosis and collected for RNA extraction. Total bacterial mRNA was analysed using real-time quantitative PCR to evaluate mRNA quantification gene expression. There were differences in the level of Rv1250 mRNA expression between sensitive (n = 11) and resistant (n = 40) groups of 5.961 ± 0.414 and 10.192 ± 1.978, respectively (fold changes; p < 0.05). There were significant differences of expression level among M. tuberculosis-resistant groups (p < 0.05) specifically 7.573 ± 0.424 for 0-month drug therapy (n = 10), 9.438 ± 0.644 for 1st month drug therapy (n = 10), 11.057 ± 0.262 for 3rd month drug therapy (n = 10) and 12.701 ± 0.460 for 5th month drug therapy (n = 10). We assume that the extent of Rv1250 gene expression in M. tuberculosis clinical isolates is a result of the exposure to antimicrobials during treatment, which affect the basic expression of the efflux pump Rv1250 gene. Keywords: Drug-resistant, efflux pump, mRNA expression level, Mycobacterium tuberculosis, Rv1250genehttp://www.sciencedirect.com/science/article/pii/S2052297519301064
collection DOAJ
language English
format Article
sources DOAJ
author F. Umar
M. Hatta
D.R. Husain
R. Natzir
R. Dwiyanti
A.R. Junita
M.R. Primaguna
spellingShingle F. Umar
M. Hatta
D.R. Husain
R. Natzir
R. Dwiyanti
A.R. Junita
M.R. Primaguna
The effect of anti-tuberculosis drugs therapy on mRNA efflux pump gene expression of Rv1250 in Mycobacterium tuberculosis collected from tuberculosis patients
New Microbes and New Infections
author_facet F. Umar
M. Hatta
D.R. Husain
R. Natzir
R. Dwiyanti
A.R. Junita
M.R. Primaguna
author_sort F. Umar
title The effect of anti-tuberculosis drugs therapy on mRNA efflux pump gene expression of Rv1250 in Mycobacterium tuberculosis collected from tuberculosis patients
title_short The effect of anti-tuberculosis drugs therapy on mRNA efflux pump gene expression of Rv1250 in Mycobacterium tuberculosis collected from tuberculosis patients
title_full The effect of anti-tuberculosis drugs therapy on mRNA efflux pump gene expression of Rv1250 in Mycobacterium tuberculosis collected from tuberculosis patients
title_fullStr The effect of anti-tuberculosis drugs therapy on mRNA efflux pump gene expression of Rv1250 in Mycobacterium tuberculosis collected from tuberculosis patients
title_full_unstemmed The effect of anti-tuberculosis drugs therapy on mRNA efflux pump gene expression of Rv1250 in Mycobacterium tuberculosis collected from tuberculosis patients
title_sort effect of anti-tuberculosis drugs therapy on mrna efflux pump gene expression of rv1250 in mycobacterium tuberculosis collected from tuberculosis patients
publisher Elsevier
series New Microbes and New Infections
issn 2052-2975
publishDate 2019-11-01
description Efflux pumps are transmembrane proteins that vigorously participate in extruding a wide range of substrates, including drugs, outside the bacterial cell. We aimed to investigate the mRNA expression level of the Rv1250 efflux pump gene in Mycobacterium tuberculosis isolated from individuals with tuberculosis who received drug therapy, at the 1st, 3rd and 5th months, and newly diagnosed patients with tuberculosis who will receive drug therapy (0 month). The study was a multiple cross-sectional longitudinal design—50 different M. tuberculosis isolates and a reference strain H37Rv were subcultured in LJ medium and confirmed by multiplex PCR for identification of M. tuberculosis and collected for RNA extraction. Total bacterial mRNA was analysed using real-time quantitative PCR to evaluate mRNA quantification gene expression. There were differences in the level of Rv1250 mRNA expression between sensitive (n = 11) and resistant (n = 40) groups of 5.961 ± 0.414 and 10.192 ± 1.978, respectively (fold changes; p < 0.05). There were significant differences of expression level among M. tuberculosis-resistant groups (p < 0.05) specifically 7.573 ± 0.424 for 0-month drug therapy (n = 10), 9.438 ± 0.644 for 1st month drug therapy (n = 10), 11.057 ± 0.262 for 3rd month drug therapy (n = 10) and 12.701 ± 0.460 for 5th month drug therapy (n = 10). We assume that the extent of Rv1250 gene expression in M. tuberculosis clinical isolates is a result of the exposure to antimicrobials during treatment, which affect the basic expression of the efflux pump Rv1250 gene. Keywords: Drug-resistant, efflux pump, mRNA expression level, Mycobacterium tuberculosis, Rv1250gene
url http://www.sciencedirect.com/science/article/pii/S2052297519301064
work_keys_str_mv AT fumar theeffectofantituberculosisdrugstherapyonmrnaeffluxpumpgeneexpressionofrv1250inmycobacteriumtuberculosiscollectedfromtuberculosispatients
AT mhatta theeffectofantituberculosisdrugstherapyonmrnaeffluxpumpgeneexpressionofrv1250inmycobacteriumtuberculosiscollectedfromtuberculosispatients
AT drhusain theeffectofantituberculosisdrugstherapyonmrnaeffluxpumpgeneexpressionofrv1250inmycobacteriumtuberculosiscollectedfromtuberculosispatients
AT rnatzir theeffectofantituberculosisdrugstherapyonmrnaeffluxpumpgeneexpressionofrv1250inmycobacteriumtuberculosiscollectedfromtuberculosispatients
AT rdwiyanti theeffectofantituberculosisdrugstherapyonmrnaeffluxpumpgeneexpressionofrv1250inmycobacteriumtuberculosiscollectedfromtuberculosispatients
AT arjunita theeffectofantituberculosisdrugstherapyonmrnaeffluxpumpgeneexpressionofrv1250inmycobacteriumtuberculosiscollectedfromtuberculosispatients
AT mrprimaguna theeffectofantituberculosisdrugstherapyonmrnaeffluxpumpgeneexpressionofrv1250inmycobacteriumtuberculosiscollectedfromtuberculosispatients
AT fumar effectofantituberculosisdrugstherapyonmrnaeffluxpumpgeneexpressionofrv1250inmycobacteriumtuberculosiscollectedfromtuberculosispatients
AT mhatta effectofantituberculosisdrugstherapyonmrnaeffluxpumpgeneexpressionofrv1250inmycobacteriumtuberculosiscollectedfromtuberculosispatients
AT drhusain effectofantituberculosisdrugstherapyonmrnaeffluxpumpgeneexpressionofrv1250inmycobacteriumtuberculosiscollectedfromtuberculosispatients
AT rnatzir effectofantituberculosisdrugstherapyonmrnaeffluxpumpgeneexpressionofrv1250inmycobacteriumtuberculosiscollectedfromtuberculosispatients
AT rdwiyanti effectofantituberculosisdrugstherapyonmrnaeffluxpumpgeneexpressionofrv1250inmycobacteriumtuberculosiscollectedfromtuberculosispatients
AT arjunita effectofantituberculosisdrugstherapyonmrnaeffluxpumpgeneexpressionofrv1250inmycobacteriumtuberculosiscollectedfromtuberculosispatients
AT mrprimaguna effectofantituberculosisdrugstherapyonmrnaeffluxpumpgeneexpressionofrv1250inmycobacteriumtuberculosiscollectedfromtuberculosispatients
_version_ 1725082939620851712